Latest Operational Resilience News

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.

Metcash Limited reported solid FY25 results with revenue rising 8.9% to $17.3 billion, driven by strong Food growth and Hardware’s late recovery. Despite a slight dip in underlying profit after tax, the company’s strategic mergers and acquisitions position it well for future expansion.

Emeco Holdings has reaffirmed its FY25 guidance, targeting $300 million in operating EBITDA and signalling confidence in earnings growth for FY26 amid disciplined cost management and a resilient mining sector.

ASIC has initiated a comprehensive compliance inquiry into ASX’s governance, risk management, and operational capabilities, folding its previous CHESS incident probe into this broader review. ASX pledges full cooperation amid ongoing technology upgrades.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Coronado Global Resources has strengthened its financial position with a $150 million liquidity injection and a pivotal five-year coal supply agreement with Stanwell Corporation, reshaping its export potential from 2027.

COSOL Limited anticipates solid revenue and earnings growth for FY25 despite some contract timing setbacks, with a promising outlook for FY26 driven by data analytics and managed services expansion.

Mayne Pharma rebuffs Cosette's claim of a material adverse change in their merger scheme and secures FDA clearance on regulatory concerns, maintaining its commitment to the deal's completion.

New Zealand King Salmon has lowered its FY26 harvest volume and earnings guidance due to slower fish growth linked to subdued feed outs during warmer months. The company aims to rebuild biomass and improve future harvests with new strategies.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Aroa Biosurgery has reported a robust 23% revenue increase in FY25, achieving profitability and positive cash flow, setting the stage for continued growth in FY26.